These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36304655)

  • 1. Evaluation of the Role of Oral Mucosal Direct Immunofluorescence and Salivary Desmoglein 1 and 3 Enzyme-Linked Immunosorbent Assay in Patients With Oral Mucosal Pemphigus.
    Asokan S; Rai R; Boppe A; Umamaheswari G
    Indian Dermatol Online J; 2022; 13(5):617-619. PubMed ID: 36304655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
    Koopai M; Mortazavi H; Khatami A; Khodashenas Z
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
    De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
    Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
    Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
    Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
    Sharma VK; Prasad HR; Khandpur S; Kumar A
    Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
    Russo I; Saponeri A; Michelotto A; Alaibac M
    In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1.
    Shirakata Y; Amagai M; Hanakawa Y; Nishikawa T; Hashimoto K
    J Invest Dermatol; 1998 Jan; 110(1):76-8. PubMed ID: 9424092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
    Barnadas MA; Rubiales MV; Gich I; Gelpí C
    Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
    Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
    Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity.
    Delavarian Z; Layegh P; Pakfetrat A; Zarghi N; Khorashadizadeh M; Ghazi A
    J Clin Exp Dent; 2020 May; 12(5):e440-e445. PubMed ID: 32509225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
    Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
    J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
    Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
    J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte Binding Assay Identifies Anti-Desmosomal Pemphigus Antibodies Where Other Tests Are Negative.
    Giurdanella F; Nijenhuis AM; Diercks GFH; Jonkman MF; Pas HH
    Front Immunol; 2018; 9():839. PubMed ID: 29740444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.